Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-30

FDA Approved: JAVYGTOR — Original Application (Dr. Reddys Laboratories Inc)

View source ↗

Summary

FDA approved JAVYGTOR (sapropterin dihydrochloride) from Dr. Reddy's Laboratories. It is a tetrahydrobiopterin (BH4) analogue used to treat phenylketonuria in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JAVYGTOR (Sapropterin dihydrochloride)

Snippet

ORIG AP for JAVYGTOR (SAPROPTERIN DIHYDROCHLORIDE)